Patient dies by suicide after "insurance issue" delayed medicine for lung disease flare-ups
A Texas man died by suicide after insurance delays prevented him from accessing medication for his chronic obstructive pulmonary disease. The case highlights ongoing criticisms regarding the American healthcare system's administrative barriers to patient care.
Why it matters
It underscores the life-altering consequences of insurance bureaucracy and the limitations of voluntary industry pledges to improve patient access.
Kyle, Texas — Kenney Blewett was diagnosed with lung disease more than a decade ago but started experiencing flare-ups this year that made him feel like he couldn't breathe.Blewett described those flare-ups as "the scariest thing in the world," said his wife, Cindy, adding that while the episodes typically lasted no more than a few minutes, they had become more frequent.On top of that, simple tasks, like taking out the trash, left Blewett winded. He rarely left the house and had recently lost 45 pounds. "That sounds like cancer," Cindy remembered one of his doctors said. It was clear, she said, that her husband's poor health, tied to decades of smoking, was getting worse.That's why, on June 2, Blewett's pulmonologist wrote him a prescription for a new medication to improve the terrifying breathing issues caused by chronic obstructive pulmonary disease, or COPD. But the prescription wasn't immediately filled.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in